DYNLL2: A Potential Drug Target for Multiple Signaling Pathways

Target Name: DYNLL2

NCBI ID: G140735

DYNLL2

DYNLL2: A Potential Drug Target for Multiple Signaling Pathways

DYNLL2 (DYL2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a member of the DYL family of proteins, which are known for their role in the regulation of cellular processes such as cell adhesion, migration, and signaling pathways.

One of the unique features of DYNLL2 is its ability to interact with multiple signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. This makes it an attractive drug target for researchers because it is involved in a wide range of physiological processes and is expressed in many different tissues, making it difficult to target with small molecules.

DYNLL2 has also been shown to play a role in the regulation of cellular processes that are important for brain development and function. For example, studies have shown that DYNLL2 is involved in the regulation of the formation and stability of synapses, which are the structures that allow neural cells to communicate with each other.

In addition to its role in brain development and function, DYNLL2 is also involved in the regulation of cellular processes that are important for the development and maintenance of various tissues and organs. For example, studies have shown that DYNLL2 is involved in the regulation of cell proliferation, migration, and the formation of tissues such as blood vessels, liver cells, and pancreatic beta cells.

DYNLL2 is also a good biomarker for some diseases, such as cancer, because it is often expressed at higher levels in tissues that are affected by the disease. This makes it a potential target for diagnostic tests and therapies that can be used to treat the disease.

In conclusion, DYNLL2 is a protein that is expressed in various tissues of the human body and is involved in a wide range of physiological processes. Its ability to interact with multiple signaling pathways makes it an attractive drug target, and its role in brain development and function makes it an important target for research into the regulation of cellular processes. Furthermore, its role in the regulation of various tissues and organs makes it a good biomarker for some diseases.

Protein Name: Dynein Light Chain LC8-type 2

Functions: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures (By similarity)

The "DYNLL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DYNLL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets